Table 1.
Characterization of % of NEO1 positive Samples (within tumor cells, blood vessels or stroma). Percentage of NEO1 positive samples according to specific clinical characteristics of the patients. 21 patient samples were analyzed and in some cases information were incomplete. We do not found association between percentage of NEO expression and clinical features. Asterisk for p value from Fisher’s exact test
| Clinical Feature | % of NEO1 positive Samples | N | χ2 | df | p-value | Fisher’s p-value | |
|---|---|---|---|---|---|---|---|
| Gender | Male | 78.0 | 7/9 | 0.112 | 1 | 0.737 | 1 |
| Female | 77.8 | 10/12 | |||||
| Age | >18 M | 83.3 | 8/10 | 0.015 | 1 | 0.9 | 1 |
| <18 M | 81.8 | 9/11 | |||||
| Tumor Stage | Disseminated (M, MS) | 80.0 | 12/15 | 0.03 | 1 | 0.86 | 1 |
| Localized (L1, L2) | 83.3 | 5/6 | |||||
| PCNA | >40% | 90.0 | 9/10 | 1.014 | 1 | 0.314 | 0.586 |
| <40% | 72.7 | 8/11 | |||||
| Primary Tumor Sites | Cervical | 66.7 | 2/3 | 0.938 | 4 | 0.919 | 1 |
| Thoracic | 100 | 2/2 | |||||
| Abdominal | 83.3 | 5/6 | |||||
| Retroperitoneal | 80.0 | 4/5 | |||||
| Adrenal | 75.0 | 3/4 | |||||
| Patient Status | Dead | 75.0 | 3/4 | 0.257 | 1 | 0.612 | 1 |
| Recovered | 85.7 | 12/14 | |||||